Cassava Sciences
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $840 | $0 | $0 |
Gross Profit | 18,982 | -200 | -5,116 | -13,666 |
EBITDA | -48,607 | -10,607 | -13,874 | -21,366 |
EBIT | -48,905 | -10,807 | -14,092 | -21,586 |
Net Income | -12,539 | -10,807 | -44,224 | -23,403 |
Net Change In Cash | 0 | 840 | 0 | 0 |
Free Cash Flow | -10,249 | -6,301 | -4,947 | -11,336 |
Cash | 95,502 | 106,080 | 112,381 | 117,328 |
Basic Shares | 48,297 | 48,293 | 48,308 | 48,262 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $-1 |
Gross Profit | -936 | -1,132 | -89,423 | -1 |
EBITDA | -94,454 | -141,146 | -104,427 | -78,719 |
EBIT | -95,390 | -142,278 | -105,957 | -80,020 |
Net Income | -90,973 | -24,342 | -97,217 | -72,472 |
Net Change In Cash | 0 | 0 | 0 | -1 |
Free Cash Flow | -32,833 | -117,032 | -82,439 | -80,226 |
Cash | 95,502 | 128,574 | 121,136 | 201,015 |
Basic Shares | 48,297 | 46,604 | 41,932 | 40,202 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $0 |
2025-09-30 | -$0.22 |
2025-06-30 | -$0.92 |
